Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Immunochemistry

• Publication date

  1973-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0019-2791(73)90221-8PMID 4796971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Further investigation of specific and non-specific adsorption of serum globulins to Staphylococcus aureus.

  2009cited by this paper
• Paroxysmal Nocturnal Hemoglobinuria

  1972cited by this paper
• Some Physicochemical Properties of Protein A from Staphylococcus aureus

  1972cited by this paper
• Localization of protein A in the bacteria.

  1972cited by this paper
• Studies of the C3 Shunt Activation in Cobra Venom Induced Lysis of Unsensitized Erythrocytes 1

  1972cited by this paper
• Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.

  1972cited by this paper
• Some physiochemical properties of protein A from Staphylococcus aureus.

  1972cited by this paper
• Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.

  1971cited by this paper
• Serum Bacteriostasis of Staphylococcus aureus

  1971cited by this paper
• Formation and function of a complement‐activating enzyme generated from factors of guinea pig serum and cobra venom

  1971cited by this paper
• The C3-activator system: an alternate pathway of complement activation.

  1971cited by this paper
• The reaction of monomeric and aggregated immunoglobulins with C1.

  1971cited by this paper
• Protein A from Staphylococcus aureus XI. Fixation of human complement and of complement from guinea pig and rabbit.

  1971cited by this paper
• Protein A from Staphylococcus aureus complement fixation by aggregates between protein A and IgG1 or IgG2 from guinea pig

  1971cited by this paper
• Isolation of the sixth component of complement from human serum.

  1971cited by this paper
• Protein A from Staphylococcus aureus conversion of complement factor C3 by aggregates between IgG and protein A

  1971cited by this paper
• Activation and inhibition of IgG mediated complement fixation by staphylococcal protein A.

  1970cited by this paper
• The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.

  1970cited by this paper
• Protein A from Staphylococcus aureus. X. Complement-fixing activity of complexes between protein A and myeloma IgG or papain fragments of IgG.

  1970cited by this paper
• THE REACTION MECHANISM OF HUMAN C5 IN IMMUNE HEMOLYSIS

  1970cited by this paper
• Protein A from Staphylococcus aureus. IX. Complement-fixing activity of protein A-IgG complexes.

  1969cited by this paper
• THE EIGHTH COMPONENT OF HUMAN COMPLEMENT (C8): ISOLATION, CHARACTERIZATION, AND HEMOLYTIC EFFICIENCY

  1969cited by this paper
• Protein A from Staphylococcus aureus. VII. Physicochemical and immunological characterization.

  1969cited by this paper
• The ninth component of human complement: isolation, description and mode of action.

  1969cited by this paper
• Complement-Immunoglobulin Relation: Deficiency of C'lq Associated with Impaired Immunoglobulin G Synthesis

  1969cited by this paper
• Protein A from Staphylococcus aureus. 8. Production of protein A by bacterial and L-forms of S. aureus.

  1969cited by this paper
• Differences in anti-protein A activity among IgG subgroups.

  1969cited by this paper
• A new rapid method for genetic typing of human immunoglobulins.

  1968cited by this paper
• A comparison of methods for the molecular quantitation of the fourth component of human complement.

  1968cited by this paper
• THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASE

  1968cited by this paper
• Protein a from Staphylococcus Aureus V. Reaction with Guinea Pig γ-Globulins

  1968cited by this paper
• Production of in vitro lytic characteristics of paroxysmal nocturnal hemoglobinuria erythrocytes in normal erythrocytes.

  1968cited by this paper
• Protein A from Staphylococcus aureus. V. Reaction with guinea pig gamma-globulins.

  1968cited by this paper
• Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

  1967cited by this paper
• THE REACTION MECHANISM OF β1C-GLOBULIN (C'3) IN IMMUNE HEMOLYSIS

  1966cited by this paper
• A molecular concept of immune cytolysis.

  1966cited by this paper
• Bacteriostatic Activity of Serum Against Staphylococci

  1966cited by this paper
• ISOLATION OF β1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT

  1965cited by this paper
• THE COMMON PROTEIN AGGLUTINOGEN OF STAPHYLOCOCCUS AUREUS. II. PURIFICATION, CHEMICAL CHARACTERIZATION, AND SEROLOGIC COMPARISON WITH JENSEN'S ANTIGEN.

  1963cited by this paper
• ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT

  1963cited by this paper
• CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

  1963cited by this paper
• FURTHER STUDIES ON THE ANTIBACTERIAL ACTIVITY OF HUMAN SERUM ON MICROCOCCUS PYOGENES AND ITS INHIBITION BY COAGULASE

  1956cited by this paper

• Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation

  2020cites this paper
• Proteína A: inmunomodulador en pacientes con cáncer

  2017cites this paper
• Study on Enzyme-Linked Immunoassay and Polymerase Chain Reaction for the Identification and Quantification of Staphylococcus aureus in Pure Culture and Food Samples

  2012cites this paper
• Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.

  2009cites this paper
• SUBSTANCES THAT CAN TRIGGER ACTIVATION OF THE ACTIVITY IN MICE

  2006cites this paper
• Host — parasite relationship in staphylococcal infections: the role of the staphylococcal cell wall during the process of phagocytosis

  2004cites this paper
• Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death.

  2002cites this paper
• A protein in the cell wall of Helicobactor pylori binds human IgG deprived of sugar chains.

  2001cites this paper
• Human blood platelet gC1qR/p33

  2001cites this paper
• Staphylococcus aureus Protein A Recognizes Platelet gC1qR/p33: a Novel Mechanism for Staphylococcal Interactions with Platelets

  2000cites this paper
• Neutrophil chemotaxis on silicone and polyurethane surfaces.

  1999cites this paper
• Solid phase activators of the alternative pathway of complement and their use in vivo

  1993cites this paper
• A Functionally Active Complement System Is Present in Uterine Secretion of the Mouse Prior to Implantation

  1991cites this paper
• Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction.

  1990cites this paper
• Antibody responses to protein A in patients with Staphylococcus aureus bacteremia and endocarditis

  1990cites this paper
• CHAPTER 2 – The type I bacterial immunoglobulin-binding protein: Staphylococcal protein A

  1990cites this paper
• CHAPTER 25 – Complement activation and bacterial immunoglobulin-binding proteins

  1990cites this paper
• Bacterial immunoglobulin-binding proteins and complement

  1990cites this paper
• Biocompatibility of extracorporeal immunoadsorption systems.

  1990cites this paper
• IgG immunoadsorption in experimental allergic neuritis: effect on antibody levels and clinical course.

  1989cites this paper
• Comparison of IgG Fc receptors from clinical isolates of Streptococcus zooepidemicus.

  1989cites this paper
• Isolation and Characterization of Fc Receptors from Haemophilus somnus

  1988cites this paper
• Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.

  1987cites this paper
• Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?

  1987cites this paper
• Biocompatibility studies on a clinically well-tolerated extracorporeal system

  1987cites this paper
• Staphylococcosis of turkeys. 2. Assay of protein A levels of staphylococci isolated from turkeys.

  1987cites this paper
• Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma. Evidence for a protein A leaking by radioimmunoassay

  1986cites this paper
• Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma. Role of the Fc‐binding capacity of protein A in the side effects and the tumoricidal response

  1986cites this paper
• Modulation of phagocytic cell function

  1986cites this paper
• Modulation of IgG effector functions by a monovalent fragment of staphylococcal protein A.

  1986cites this paper
• Protein A and staphylococcal products in neoplastic disease.

  1985cites this paper
• STAPHYLOCOCCAL PROTEIN A COLUMN: ITS MECHANISM OF ACTION1

  1985cites this paper
• Cancer treatment with Staphylococcus aureus protein A.

  1985cites this paper
• Complement and cancer: activation of the alternative pathway as a theoretical base for immunotherapy.

  1985cites this paper
• Blocking (suppressor) factors, immune complexes, and extracorporeal immunoadsorption in tumor immunity.

  1985cites this paper
• Immunoglobulin G: functional sites.

  1985cites this paper
• A simple two-step procedure for the preparation of the first component of human complement (C1) in its native form.

  1985cites this paper
• Antitumor activity of protein a administered intravenously to pet cats with leukemia or lymphosarcoma

  1985cites this paper
• Staphylococcal Protein A column: correlation of mitogenicity of perfused plasma with clinical response.

  1985cites this paper
• Mutual inhibition of the binding of Clq and protein A to rabbit IgG immune complexes.

  1985cites this paper
• Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagents.

  1985cites this paper
• Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.

  1984cites this paper
• Comparative Morphologic Changes in Canine and Human Breast Adenocarcinoma After Treatment with Plasma Perfused Over Immobilized Protein A

  1984cites this paper
• Comparison of the bio-physical and biological properties of staphylococcal protein-A extracted by salt-washing and conventional procedure.

  1984cites this paper
• Electron microscopic and hydrodynamic studies of protein A-immunoglobulin G soluble complexes.

  1984cites this paper
• Use of enzyme-linked immunosorbent assay to detect antibodies to staphylococcal protein A in the rabbit.

  1984cites this paper
• A model for the formation and interconversion of protein A-immunoglobulin G soluble complexes.

  1984cites this paper
• IgG-protein A complexes modulate thymidine incorporation into DNA of antibody and complement-stimulated cells.

  1984cites this paper
• The C1q receptor site on human immunoglobulin G.

  1984cites this paper
• Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.

  1984cites this paper
• Staphylococcal protein A immunoadsorptive column induces mitogenicity in perfused plasma.

  1984cites this paper
• Histological and ultrastructural changes in breast adenocarcinoma after treatment with plasma perfused over immobilized protein A.

  1984cites this paper
• Clinical response to protein a-treated plasma infusions and in vitro correlation.

  1984cites this paper
• Isolation of antigenic proteins from lymphocytes by binding immune complexes to staphylococcal protein A.

  1984cites this paper
• Use of protein A in the detection and quantitation of immunoglobulin G on the surface of lymphocytes.

  1984cites this paper
• Substances that can trigger activation of the alternative pathway of complement have anti‐melanoma activity in mice

  1984cites this paper
• Ultrastructural changes in breast tumors of patients following treatment with plasma perfused over immobilized protein A.

  1984cites this paper
• Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.

  1984cites this paper
• The use of staphylococcal protein A in diagnostic virology.

  1983cites this paper
• Natural antibodies against a polysaccharide (Bo) from sugar cane mediate its complement-activating effect.

  1983cites this paper
• Immune complex assays and stored normal human sera.

  1983cites this paper
• Protein a treatment of cancer: Activation of a serum component with trans‐species anti‐B16 melanoma activity

  1983cites this paper
• Demonstration of high and low affinity complexes between protein A and rabbit immunoglobulin G antibodies depending on hapten density.

  1982cites this paper
• Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.

  1982cites this paper
• Selective adsorption of IgG and IgM: evaluation of systems for plasma exchange.

  1982cites this paper
• The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease?

  1982cites this paper
• IN STAPHYLOCOCCAL DISEASE

  1981cites this paper
• Leupeptin inhibits the C3/5 convertase CVFBb of the complement system.

  1981cites this paper
• Host determinants in staphylococcal disease.

  1981cites this paper
• Tumoricidal responses in spontaneous canine neoplasms after extracorporeal perfusion over immobilized protein A.

  1981cites this paper
• The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq.

  1981cites this paper
• Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus

  1981cites this paper
• Inhibition of the classical complement pathway by synthetic peptides from the second constant domain of the heavy chain of human immunoglobulin G.

  1981cites this paper
• Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A.

  1981cites this paper
• A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.

  1981cites this paper
• Immunology of Staphylococci

  1981cites this paper
• Interaction of Human Polyclonal IgE and IgG from Different Species with Protein A from Staphylococcus aureus: Demonstration of Protein‐A‐reactive Sites Located in the Fab2 Fragment of Human IgG

  1980cites this paper
• Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowans I. I. Description of acute tumoricidal response: morphologic, histologic, immunohistochemical, immunologic, and serologic findings.

  1980cites this paper
• Complement activation in Staphylococcus aureus bacteraemia.

  1980cites this paper
• Immune complex formation enhances the binding of staphylococcal protein A to immunoglobulin G.

  1980cites this paper
• Corneal Inflammation and Complement

  1979cites this paper
• Activated complement in the sputum from patients with cystic fibrosis.

  1979cites this paper
• The role of natural IgG and complement in the phagocytosis of type 4 Neisseria gonorrhoeae by human polymorphonuclear leukocytes.

  1979cites this paper
• Chemotaxigenesis by cell surface components of Staphylococcus aureus

  1979cites this paper
• The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

  1979cites this paper
• [Comparative analysis of the interaction of protein A from Staphylococcus aureus with native, reduced and aggregated IgG].

  1979cites this paper
• IMMUNE COMPLEXES IN THE SPUTUM OF PATIENTS WITH CYSTIC FIBROSIS SUFFERING FROM CHRONIC PSEUDOMONAS AERUGINOSA LUNG INFECTION

  1978cites this paper
• Interactions between staphylococcal protein A and immunoglobulin domains.

  1978cites this paper
• Induced staphylococcal infections in the bovine mammary gland.

  1978cites this paper
• The role of protein A in the attachment of staphylococci to influenza-infected cells.

  1978cites this paper
• Opsonins in human serum for the phagocytosis of complexes between IgG and protein A of Staphylococcus aureus.

  1978cites this paper
• Circulating immune complexes during immunotherapy.

  1978cites this paper
• Activation of the alternate complement pathway in Staph. aureus infective endocarditis and its relationship to thrombocytopenia, coagulation abnormalities, and acute glomerulonephritis.

  1978cites this paper
• Activation of complement by cell surface components of Staphylococcus aureus

  1978cites this paper
• Lung clearance of Staphylococcus aureus strains with differing protein A content: protein A effect on in vivo clearance

  1978cites this paper
• Role of complement in corneal inflammation.

  1978cites this paper
• The surface properties of Neisseria gonorrhoeae: determinants of susceptibility to antibody complement killing.

  1978cites this paper
• Classical and alternative complement pathway activation by pneumococci

  1977cites this paper
• Corneal rings with gram-negative bacteria.

  1977cites this paper
• Alternative Modes and Pathways of Complement Activation

  1977cites this paper